Musicco C, Capelli V, Pesce V, Timperio AM, Calvani M, Mosconi L, et al
It also suppresses glucagon secretion, slows gastric emptying, and acts on appetite centres in the brain to promote satiety and reduce food intake
Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated mean body weight reductions of up to approximately 24% over 48 weeks in adults with obesity a notable finding, though long-term durability data and head-to-head comparisons with other treatments are not yet available
Next Steps Choosing between tirzepatide and semaglutide requires careful consideration of your metabolic profile, treatment goals, and individual response patterns
If you have digestive issues, fix them first